aim
studi
de
termin
furth
r
charact
rize
se
rum
aminop
ptidas
childr
n
live
r
dise
ase
base
ne
w
assay
shown
two
fraction
e
nzyme
activ
rst
fraction
e
xpre
sse
undilut
se
rum
ph
adjust
ph
storag
se
rum
activ
se
cond
fraction
cryptic
activ
app
ar
serum
ph
result
dilut
andor
addit
anilin
naphthal
ne
sulfon
acid
childr
n
alagil
syndrom
e
xtrahe
patic
biliari
duct
atr
sia
byle
r
dise
ase
acut
hepat
due
patiti
b
viru
infect
activiti
fraction
highli
elev
compar
healthi
childr
n
chronic
viral
patiti
se
rum
aminopeptidas
se
em
ct
oth
r
asp
ct
patholog
proce
ss
alanin
aminotransf
rase
g
glutamyltransp
ptidas
due
incr
ase
activ
broad
substrat
citi
e
nzyme
se
e
ms
also
cofactor
chole
stasi
patiti
membran
bound
aminop
ptidas
ec
function
ectopeptidas
cell
surfac
mani
tissu
also
solubl
form
e
nzyme
serum
oth
r
serum
aminop
ptidas
activ
mark
dli
increas
pati
nt
chole
stasi
shown
use
ful
mark
r
patobiliari
dise
ase
enzym
thought
origin
live
r
howe
ver
multipl
mole
cular
form
pre
sent
se
rum
may
aris
oth
r
organ
tissu
matolog
aminop
ptidas
cluster
diff
rentiat
wellrecogn
marker
mye
loid
cell
le
uke
mia
int
restingli
bee
n
found
aminop
ptidas
alim
ntari
spiratori
tract
e
pith
lial
cell
receptor
human
coronaviru
larg
popul
appar
ntli
healthi
human
e
nzyme
activ
se
em
e
xhibit
variat
depe
nde
nt
age
se
x
alcohol
consumpt
smoke
drug
intak
among
substrat
aminop
ptidas
includ
involv
growth
differ
ntiation
gulat
phagocytosi
bact
ricid
tumoricid
activ
methionin
met
le
ucin
le
u
enkephalin
rapidli
de
grade
aft
r
ir
administr
human
anim
circul
e
ndoge
nou
enkephalin
se
em
prote
cted
de
gradat
bind
carrier
prote
in
howev
r
fre
e
fraction
e
nke
phalin
would
susc
ptibl
e
nzyme
enkephalin
app
ar
implic
chole
static
live
r
dise
ase
may
import
pathog
nic
factor
complic
pruritu
e
nce
phalopathi
ind
e
plasma
e
nke
phalin
concentr
highli
elev
adult
pati
nt
chole
stasi
diff
ring
aetiologi
rat
e
xpe
rime
ntal
mode
l
acut
chole
stasi
accumul
blood
e
nke
phalin
may
cross
brain
barri
r
evok
via
ir
incr
ase
avail
central
nervou
syst
syndrom
chronic
opiat
receptor
stimul
preliminari
experi
shown
naloxon
nalm
fene
opiat
receptor
antagonist
ame
liorat
reve
rsed
pruritu
pati
nt
chronic
chole
static
live
r
diseas
pati
nt
pre
cipit
syndrom
rese
mble
withdraw
reaction
opiat
addict
recent
shown
childr
n
chole
stasi
diff
ring
e
tiologi
incr
ase
se
rum
metenkephalin
occur
concom
itantli
highli
ele
vate
se
rum
aminop
ptidas
activ
param
ter
appar
ntli
aff
cted
shortt
rm
treatment
ursod
oxychol
acid
altern
aminop
ptidas
activ
well
ir
le
vanc
situat
chole
stasi
viral
patiti
fulli
und
rstood
yet
furth
r
syst
matic
studi
see
worthwhil
fore
studi
attempt
furth
r
character
compar
serum
aminop
ptidas
activ
althi
childr
n
childr
n
chole
static
live
r
dise
ase
childr
n
chronic
acut
patiti
due
hepat
b
viru
hbv
inf
ction
patient
protocol
studi
approv
hospit
ethic
committ
e
follow
group
pati
nt
includ
studi
group
e
ight
children
ye
ar
old
year
alagil
syndrom
arterioh
patic
dysplasia
alanin
inotransf
rase
alat
blood
sam
p
ling
v
enou
blood
sampl
without
anticoagul
diagnost
examin
possibl
use
part
e
ach
sampl
studi
blood
sampl
centrifug
min
sera
ltere
lte
r
sartoriusm
lte
r
gottingen
ge
rmani
exclud
residu
cell
debri
store
serum
ph
asur
use
ph
microelectrod
sigma
chemic
co
st
loui
missouri
assay
inop
eptid
asem
activ
equal
aliquot
l
sera
pool
group
respect
ly
use
character
aminopeptidasem
e
nzyme
activ
also
dete
rmine
individu
serum
sampl
patient
group
dilut
serum
perform
use
mmollit
ace
tic
acid
buff
r
without
mollit
nacl
ph
rang
maintain
serum
ph
desir
leve
l
endogen
hco
hydrolyz
neglig
volum
mollit
hcl
nal
concentr
mmol
liter
result
co
remov
low
pressur
ph
adjust
small
volum
mollit
nao
h
hcl
ace
tic
acid
control
ph
microelectrod
incub
mixtur
consist
l
undilut
dilut
serum
l
incub
perform
min
control
min
termin
cation
mmoll
ace
tic
acid
de
gradat
substrat
e
aluminum
silic
bind
assay
recent
describ
slight
cation
homogen
suspens
mgml
aluminum
silic
powder
lloyd
reag
nt
pfaltz
bauer
wate
rburi
connecticut
prepar
acet
acid
aliquot
ml
add
tube
e
nd
incub
period
aft
r
vortex
min
tube
centrifug
min
leuenkephalin
supernat
discard
aspir
silic
pellet
count
g
radioact
h
leue
nkephalin
aliquot
supernat
mix
ml
aliquot
scintil
cocktail
count
b
radioact
intraand
interassay
cient
variat
iodin
tritiat
e
nkephalin
respect
ly
e
nzyme
activ
e
xpress
picogram
degrad
substrat
per
minut
per
millilit
whole
serum
intact
h
leuenkephalin
almost
complet
ly
adsorb
aluminum
silic
sem
n
reve
rsephas
highperform
liquid
chromatographi
show
silic
pelletbound
radioact
pre
se
nte
intac
labe
le
pe
ptide
wherea
radioact
appear
supernat
due
h
tyrosin
e
two
three
amino
acid
fragm
nt
constitut
radioact
react
c
leue
nkephalin
antibodi
data
shown
effect
inhibitor
oth
er
sub
tan
ce
inop
eptidasem
degrad
label
leuenkephalin
serum
aminopeptidasem
e
dete
rmine
percentag
intact
label
presenc
increas
concentr
e
substanc
ext
nt
label
degrad
control
probe
substanc
ad
degrad
aft
r
e
incub
period
take
n
rel
activ
assay
inhibitor
test
preincub
serum
min
inhibitori
constant
k
micha
constant
k
toward
unlabel
leue
nkephalin
determin
previous
describ
follow
substanc
use
present
studi
purchas
sigma
nanthrolin
bestatin
puromycin
leue
nkephalin
te
nkephalin
bovin
serum
albumin
naphthalen
sulfon
an
acid
taurochol
acid
ursodeoxychol
acid
cholic
acid
chemic
analyt
grade
stati
tical
alysi
v
alu
e
xpress
mean
se
unless
otherwis
ed
mannwhitn
u
test
use
dete
rmine
canc
differ
betw
en
mean
p
consid
cant
storag
serum
ph
rise
e
ffect
ph
aminop
ptidas
activ
undilut
se
rum
pool
group
shown
figur
ph
curv
symm
tric
dynam
optimum
iodin
tritiat
le
ue
nkephalin
data
obtain
e
xpe
rime
nt
dilut
se
ra
increas
serum
aminop
ptidas
activ
result
dilut
mmollit
r
buff
r
ph
shown
figur
b
shown
figur
e
nzyme
activ
increas
undilut
se
rum
ph
maxim
al
valu
pgminml
dilut
serum
valu
mean
sem
statist
cant
diff
nce
aminop
ptidas
activ
twe
e
n
althi
childr
n
chronic
activ
patiti
due
hbv
inf
ction
p
shown
figur
e
nzyme
activ
undilut
se
ra
ph
childr
n
alagil
syndrom
extrah
patic
biliari
duct
atr
sia
byler
dise
ase
acut
patiti
due
hbv
inf
ction
pgminml
spe
ctive
ly
sampl
dilut
activ
ach
maxim
valu
pgm
inml
spe
ctive
ly
neglig
dilut
without
eff
ct
figur
b
data
obtain
e
xpe
r
ime
nt
whe
buff
salin
ph
se
rved
se
rum
dilu
nt
data
shown
effect
incr
ase
concentr
an
acid
aminop
ptidas
activ
shown
figur
undilut
dilut
sera
e
nzyme
activ
incr
ase
twice
prese
nce
mmollit
r
an
acid
resp
ctive
dilut
optim
al
conc
ntration
c
an
acid
may
estim
follow
e
mpiric
formula
c
millimol
pe
r
liter
whe
fold
dilut
serum
high
r
an
acid
conc
ntration
inhibitori
e
nzyme
activ
decreas
basal
le
vel
an
acid
add
inhibit
substrat
citi
data
serum
aminop
ptidas
se
rum
pool
group
shown
tabl
undilut
dilut
se
ra
puromycin
statin
amastatin
inhibit
e
nzyme
k
valu
mollit
r
mollit
r
nmollit
r
spectiv
ly
prese
nce
an
acid
enzym
se
nsitiv
inhibitor
chang
certain
de
gre
e
howe
ver
pote
nci
se
le
ctiviti
rang
inhibitor
main
unchang
k
valu
de
te
rmine
leue
nke
phalin
substrat
mollit
r
undilut
dilut
se
ra
group
tabl
aminop
ptidas
activ
individu
sera
group
evalu
und
r
diff
nt
assay
condit
sult
shown
tabl
undilut
sampl
ph
e
nzyme
activ
statist
cantli
und
restim
p
compar
sampl
ph
adjust
physiolog
le
vel
maxim
enzym
activ
observ
sampl
dilut
se
rum
aminop
ptidas
activ
statist
cantli
high
r
childr
n
cholestasi
acut
patiti
compar
althi
childr
n
chronic
activ
hepat
p
att
mpte
de
te
rmine
charact
rize
e
xpre
ssion
prope
rtie
se
rum
aminop
ptidas
activ
childr
n
live
r
diseas
althi
childr
n
shown
pre
senc
two
fraction
enzym
activ
rst
fraction
basic
activ
e
xpre
ssed
undilut
ne
gligibl
dilut
se
rum
ph
activ
se
cond
fraction
cryptic
activ
app
ar
serum
sult
dilut
andor
addit
an
acid
childr
n
chole
stasi
childr
n
acut
patiti
due
hbv
infect
fraction
e
nzyme
highli
elev
compar
althi
childr
n
chronic
activ
patiti
due
hbv
infect
sinc
enkephalin
among
wellcharact
rize
natur
aminop
ptidas
substrat
assay
use
radiolab
le
le
ue
nkephalin
concentr
close
peptid
leve
l
circul
h
le
ue
nkephalin
biolog
indistinguish
nativ
pe
ptide
whe
rea
substitut
iodin
see
mingli
nced
substrat
e
nzyme
int
raction
sult
slightli
de
creas
rate
hydrolysi
figur
enzym
ph
optimum
narrow
activ
dramat
decreas
outsid
rang
one
free
thaw
cycl
ph
se
rum
increas
due
ne
ar
compl
te
co
evapor
avoid
se
riou
und
stimat
enzym
activ
se
rum
ph
must
care
adjust
alt
rnativ
ly
enzym
ph
optim
um
maintain
serum
ph
may
achi
dilut
se
rum
appropri
buff
r
howe
ver
shown
dilut
anoth
r
factor
aff
cting
serum
aminop
ptidas
activ
whe
r
ph
play
role
vivo
gulat
e
nzyme
activ
main
determin
aminop
ptidas
activ
dynam
increas
sult
dilut
serum
simpl
buffer
buff
red
salin
plate
au
activ
found
sampl
dilut
neglig
dilut
without
e
ffe
ct
althi
childr
n
childr
n
chronic
activ
patiti
due
hbv
inf
ction
enzym
activ
incr
ase
undilut
serum
pgminm
l
dilut
serum
childr
n
byler
diseas
spectiv
valu
pgminml
high
st
incr
ase
found
childr
n
alagil
syndrom
pgminm
l
e
xtrahe
patic
biliari
duct
atresia
pgminml
acut
patiti
due
hbv
infect
pgminml
mani
port
includ
serum
dilut
take
n
account
factor
may
affect
aminop
ptidas
activ
increas
e
nzyme
activ
result
dilut
sugg
st
larg
portion
enzym
molecul
hydrolyt
activ
prese
nt
se
rum
cryptic
fraction
may
due
prese
nce
enzym
natur
inhibitor
dissoci
result
dilut
assumpt
true
n
increas
se
rum
aminop
ptidas
chole
stasi
acut
patiti
due
cie
nci
inhibitor
sinc
fraction
enzym
highli
e
levat
activ
e
nzyme
may
occur
vivo
centli
martin
z
cowork
rs
shown
serum
aminop
ptidas
activ
rat
capabl
chang
rapidli
spons
environment
e
xpe
rie
nce
howev
r
mechan
e
nzyme
activ
sult
se
rum
dilut
main
de
te
rmine
addit
an
acid
capabl
disrupt
weak
bond
incr
ase
serum
aminop
ptidas
activ
dose
de
pe
nde
nt
mann
r
figur
howe
ver
mechan
incr
ase
enzym
activ
an
acid
dilut
se
em
diff
rent
factor
app
ar
act
ind
pe
nde
ntli
e
nzyme
structur
gulatori
factor
ur
inhibit
citi
data
shown
substanti
charact
ristic
e
nzyme
undilut
dilut
sera
de
te
rmine
without
pre
senc
an
acid
ur
data
sugg
st
liabl
aminop
ptidas
assay
may
perform
use
picomolar
conc
ntration
e
nke
phalin
labe
le
iodin
tritium
add
ne
gligibl
volum
e
aliquot
undilut
se
rum
ph
adjust
physiolog
leve
l
maxim
e
nzyme
activ
may
de
te
rmine
use
te
se
rum
hemolysi
must
avoid
sinc
e
rythrocyt
contain
abund
e
nke
phalind
grade
activ
use
e
dta
plasma
phosphat
citrat
barbit
buffer
mark
dli
decreas
e
nzyme
activ
monitor
aminop
ptidas
activ
vari
ty
substrat
techniqu
may
appli
howe
ver
shown
se
nsitiv
fast
inexp
nsive
alum
inum
silic
ate
bind
assay
e
xce
lle
nt
method
detect
degrad
hor
ilab
le
enkephalin
chole
stasi
associ
accumul
e
nkephalin
oth
r
opiat
peptid
blood
may
contribut
pathog
nesi
pruritu
encephalopathi
whe
r
opioid
syst
alt
acut
viral
patiti
remain
de
te
rmine
although
origin
e
nkephalin
cholestasi
unknown
see
ms
impairm
ent
patic
degrad
pe
ptide
doe
occur
refor
increas
serum
aminop
ptidas
chole
stasi
may
specul
home
ostat
att
mpt
preve
nt
unlim
ite
accumul
opiat
pe
ptide
circul
howe
ver
due
increas
activ
e
nzyme
see
ms
caus
substanti
chang
turnov
r
oth
r
biolog
activ
peptid
blood
fore
suggest
e
nzyme
marker
also
cofactor
diseas
sourc
se
rum
aminop
ptidas
prove
n
e
nzyme
thought
origin
live
r
patocyt
membran
bound
metallop
ptidas
virtual
abs
nt
patocyt
cytosol
e
nzyme
may
oth
r
pathway
asp
ct
patholog
proce
ss
se
rum
alat
g
gtp
ind
ed
pati
nt
byle
r
diseas
se
e
mate
rial
thod
normal
le
vel
se
rum
g
gtp
moder
ly
increas
alat
high
le
vel
aminop
ptidas
contrast
childr
n
activ
chronic
patiti
e
levat
leve
ls
g
gtp
alat
normal
aminop
ptidas
activ
among
six
pati
nt
acut
patiti
due
hbv
inf
ction
alat
unitslit
r
two
pati
nt
mode
rate
elev
g
gtp
highli
incr
ase
aminop
ptidas
activ
whe
rea
four
oth
r
pati
nt
e
xhibit
high
incr
ase
param
ter
aminop
ptidas
serum
e
xhibit
high
amplitud
chang
chole
stasi
acut
viral
patiti
howev
r
physiolog
pathophysiolog
role
well
levanc
situat
chole
static
live
r
dise
ase
viral
patiti
quir
furth
r
studi
data
se
e
provid
ne
w
import
insight
furth
r
studi
role
e
nzyme
